The second step of the analgesic ladder and oral tramadol in the treatment of mild to moderate cancer pain: A systematic review

Palliative Medicine

Volumn 25, Issue 5, 2011, Pages 410-423

  Tassinari, Davide ^a,c   Drudi, Fabrizio ^a   Rosati, Marta ^b   Tombesi, Paola ^c   Sartori, Sergio ^c   Maltoni, Marco ^b  

^a City Hospital   (Italy)

^b ASL3 Genovese   (Italy)

^c Department of Internal Medicine ^*  (Italy)

Author keywords

neoplasm; opioids; oral tramadol; Pain

Indexed keywords

BUPRENORPHINE; CODEINE; DEXTROPROPOXYPHENE; HYDROCODONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PLACEBO; TRAMADOL;

CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HUMAN; LOW DRUG DOSE; MEDICAL LITERATURE; META ANALYSIS; NEUROPATHIC PAIN; PATIENT PREFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 79959905204     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216311405090     Document Type: Conference Paper

References (44)

1. World Health Organization. Cancer pain relief. Geneva: WHO, 1986.
2. Cancer pain relief. 2 nd ed Geneva: WHO ; 1996 :
3. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987 ; 59: 850-856 (Pubitemid 17018769)
4. Zech D, Grond S, Lynch J, Hertel D, Lehmann K. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995 ; 63: 65-76
5. Mercadante S. Pain treatment and outcomes for patients with advanced cancer who receive follow up care at home. Cancer. 1999 ; 85: 1849-1858 (Pubitemid 29169688)
6. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management: stepping up the quality of its evaluation. J Am Med Assoc. 1995 ; 274: 1870-1873 (Pubitemid 26001265)
7. Walker VA, Hoskin PJ, Hanks GW, White ID. Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Symptom Manage. 1988 ; 3: 145-149
8. Goisis A, Gorini M, Ratti R, Luliri P. Application of a WHO protocol on medical therapy for oncologic pain in an internal medicine hospital. Tumori. 1989 ; 75: 470-472 (Pubitemid 20064228)
9. Ventafridda V, Caraceni A, Gamba A Advances in pain research and therapy. Foley KM Bonica JJ Ventafridda V Callaway MV, ed. New York: Raven Press ; 1990: 451-464.
10. Takeda F Advances in pain research and therapy. Foley KM Bonica JJ Ventafridda V Callaway MV, ed. New York: Raven Press ; 1990: 475-483.
11. Wenk R, Diaz C, Echeverria M, et al. Argentina's WHO cancer pain relief program: a patient care model. J Pain Symptom Manage. 1991 ; 6: 40-43
12. Siguan SS, Damole AA, Mejarito AG. Results of cancer pain treatment at Southern Island Medical Center, Cebu, Philippines. Phillippine J Surg Specialities. 1992 ; 47: 173-176
13. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001 ; 19: 2542-2554 (Pubitemid 32391226)
14. Mercadante S, Salvaggio L, Dardanoni G, et al. Dextropropoxyfene versus morphine in opioid-naive cancer patients with pain. J Pain Symptom Manage. 1998 ; 15: 76-81 (Pubitemid 28109828)
15. Mercadante S, Porzio G, Ferrera P, et al. Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manage. 2006 ; 31: 242-247
16. Marinangeli F, Ciccozzi A, Leonardis M, et al. Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage. 2004 ; 27: 409-416 (Pubitemid 38569646)
17. Hanks GW, Reid C, Forbes K. Use of strong opioids in advanced cancer pain. J Pain Symptom Manage. 2005 ; 29: 113-114
18. Maltoni M, Scarpi E, Modonesi C, et al. A validation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Care Canc. 2005 ; 13: 888-894 (Pubitemid 41502248)
19. Leppert W, Luczak J. The role of tramadol in cancer pain treatment. A review. Support Care Canc. 2005 ; 13: 5-17 (Pubitemid 40193060)
20. Rodriguez RF, Castillo JM, Castillo MdP, et al. Codeine/paracetamol and hydrocodone/paracetamol combination tablets for the management of chronic cancer pain in adults: a 23-days, prospective, double-blind, randomized, parallel-group study. Clin Ther. 2007 ; 29: 582-587
21. Kalso E. Oxycodone. J Pain Symptom Manage. 2005 ; 29: 47-56
22. Kpizumi W, Toma H, Watanabe K, et al. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer patients, starting with 5 mg tablets. Jpn J Clin Oncol. 2004 ; 34: 608-614 (Pubitemid 40662716)
23. Grading quality of evidence and strength of recommendations. Br Med J. 2004 ; 328: 1490-1497
24. Atkins D, Eccles M, Flottorp S, et al. System for grading the quality of the evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res. 2004 ; 4: 38-38
25. Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. Br Med J. 2008 ; 336: 1049-1051
26. Guyatt GH, Oxman AD, Kunz R, et al. What is 'quality of evidence' and why is it important to clinicians?. Br Med J. 2008 ; 336: 995-998 (Pubitemid 351656090)
27. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J. 2008 ; 336: 924-926 (Pubitemid 351632017)
28. Schunemann HJ, Best D, Vist G, et al. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. Can Med Assoc J. 2003 ; 169: 677-680 (Pubitemid 37266979)
29. Montori VM, Guyatt GH. Progress in evidence-based medicine. J Am Med Assoc. 2008 ; 300: 1814-1816
30. Arbaiza D, Vidal O. Tramadol in the treatment of neuropathic cancer pain: a double-blind, placebo-controlled study. Clin Drug Investig. 2007 ; 27: 75-83 (Pubitemid 46058736)
31. Mercadante S, Arcuri E, Fusco F, et al. Randomized, double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain. Support Care Canc. 2005 ; 13: 702-707 (Pubitemid 41435561)
32. Rodriguez RF, Castillo JM, Castillo MP, et al. Hydrocodone/acetamonophen and tramadol chloridrate combination tablets for the management of chronic cancer pain: a double-blind comparative trial. Clin J Pain. 2008 ; 24 (1). 1-4
33. Rodriguez RF, Bravo LE, Castro F, et al. Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial. J Palliat Med. 2007 ; 10: 56-60 (Pubitemid 46238953)
34. Brema F, Pastorino G, Martini MC, et al. Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial. Int J Clin Pharm Res. 1996 ; 16: 109-116 (Pubitemid 27217781)
35. Tawfik MO, Elborolossy K, Nasr F. Tramadol hydrochloride in the relief of cancer pain. A double blind comparison against sustained release morphine. Proc VI World Congress on Pain Adelaide 1990. Pain. 1990 ; S377: 728a - 728a
36. Osipova NA, Novikov GA, Beresnev VA, et al. Analgesic effect of tramadol in cancer patients with chronic pain: a comparison with prolonged-action morphine sulphate. Curr Ther Res. 1991 ; 50: 812-821
37. Grond S, Radbruch L, Meuser T, et al. High-dose tramadol in comparison to low-dose morphine for cancer pain relief. J Pain Symptom Manage. 1999 ; 18: 174-179 (Pubitemid 29459122)
38. Rodrigues N, Rodrigues Pereira E. Tramadol in cancer pain. Curr Ther Res. 1989 ; 46: 1142-1148 (Pubitemid 20028346)
39. Grond S, Zech D, Lynch J, et al. Tramadol, a weak opioid for relief of cancer pain. Pain Clin. 1992 ; 5: 241-247 (Pubitemid 23032817)
40. Wilder-Smith CH, Schimke J, Osterwalder B, et al. Oral tramadol, a μ-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain. Ann Oncol. 1994 ; 5: 141-146
41. Bono AV, Cuffari S. Efficacitè et tolerance du tramadol dans les douleurs neoplasiques. Drugs. 1997 ; 53 (supplement 2). 40-49 (Pubitemid 27174067)
42. Petzke F, Radbruch L, Sabatowsky R, et al. Slow-release tramadol for treatment of chronic malignant pain. An open multicenter trial. Support Care Canc. 2000 ; 9: 48-54
43. Leppert W. Analgesic efficacy and side effects of oral tramadol and morphine administered orally in the treatment of cancer pain. Nowotwory. 2001 ; 51: 257-266 (Pubitemid 32937401)
44. Tassinari D, Sartori S. Transdermal opiates and pain: evidence for future trials and actual clinical practice. J Palliat Care. 2009 ; 25: 301-301